Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Astellas Pharma Inc (ALPMF)

Astellas Pharma Inc (ALPMF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 22.29
  • Price/Book 3.03
Trade ALPMF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.7400 +5.31%
on 03/13/24
11.6200 -2.67%
on 03/04/24
+0.6900 (+6.50%)
since 02/14/24
3-Month
10.6200 +6.50%
on 02/14/24
12.5210 -9.67%
on 01/05/24
-0.1100 (-0.96%)
since 12/18/23
52-Week
10.6200 +6.50%
on 02/14/24
17.0000 -33.47%
on 05/25/23
-2.7100 (-19.33%)
since 03/06/23

Most Recent Stories

More News
Why Shares of Adaptive Biotechnologies Jumped This Week

The company could see its first FDA-approved therapy as early as next year.

ALPMF : 11.3100 (+5.31%)
ADPT : 3.18 (-1.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 11.3100
2nd Resistance Point 11.3100
1st Resistance Point 11.3100
Last Price 11.3100
1st Support Level 11.3100
2nd Support Level 11.3100
3rd Support Level 11.3100

See More

52-Week High 17.0000
Fibonacci 61.8% 14.5628
Fibonacci 50% 13.8100
Fibonacci 38.2% 13.0572
Last Price 11.3100
52-Week Low 10.6200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar